Market Recap Check: Blueprint Medicines Corp (BPMC)’s Positive Finish at 2.73M, Up/Down 4504559

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The price of Blueprint Medicines Corp (NASDAQ: BPMC) closed at $2.73M in the last session, up 4504559% from day before closing price of $128.12. In other words, the price has increased by $4504559 from its previous closing price. On the day, 4.5 million shares were traded. BPMC stock price reached its highest trading level at $128.3 during the session, while it also had its lowest trading level at $128.0.

Ratios:

We take a closer look at BPMC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 2.08 whereas as Long-Term Debt/Eq ratio is at 1.72.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when Carter Percy H. sold 2,659 shares for $127.88 per share. The transaction valued at 340,033 led to the insider holds 54,206 shares of the business.

Albers Jeffrey W. sold 5,000 shares of BPMC for $505,692 on May 27 ’25. The Director now owns 146,630 shares after completing the transaction at $101.14 per share. On May 27 ’25, another insider, Albers Jeffrey W., who serves as the Director of the company, bought 5,000 shares for $101.14 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BPMC now has a Market Capitalization of 8290193920 and an Enterprise Value of 8416526336. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.75 while its Price-to-Book (P/B) ratio in mrq is 24.19. Its current Enterprise Value per Revenue stands at 14.973 whereas that against EBITDA is -53.146.

Stock Price History:

The Beta on a monthly basis for BPMC is 0.83, which has changed by 0.20829403 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, BPMC has reached a high of $128.34, while it has fallen to a 52-week low of $73.04. The 50-Day Moving Average of the stock is 24.08%, while the 200-Day Moving Average is calculated to be 33.77%.

Shares Statistics:

According to the various share statistics, BPMC traded on average about 2.73M shares per day over the past 3-months and 4448610 shares per day over the past 10 days. A total of 64.56M shares are outstanding, with a floating share count of 62.30M. Insiders hold about 3.67% of the company’s shares, while institutions hold 106.82% stake in the company. Shares short for BPMC as of 1748563200 were 6084118 with a Short Ratio of 2.23, compared to 1745971200 on 5657079. Therefore, it implies a Short% of Shares Outstanding of 6084118 and a Short% of Float of 10.6000006.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.